Vivace Longevity Fund I LP
Raised
Pre-open
Investors
—
Min Invest
None stated
Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.
AltStreet Analysis
·Generated from EDGAR primary sources
Vivace Longevity Fund I LP is a Delaware limited partnership organized as a pooled investment fund, filing Form D under Rule 506(b) and the Section 3(c)(1) exclusion. The filing is an original (non-amendment) submission with the offering in a pre-open state — no first sale date, total amount sold, or investor count has been disclosed. Executive officers listed are the fund's GP entity (Vivace Longevity Fund I GP LLC), Vivace Partners LLC, Dylan Livingston, and Matthew Kaeberlein; no parent platform match or related sibling entities were identified.
This filing fits the standard pattern for a newly formed private fund raising capital from accredited investors under 506(b) while relying on the 3(c)(1) exclusion to stay under the 100-investor limit for private funds — a common structure for smaller, closely-held vehicles rather than broadly marketed offerings. No minimum investment is stated on the filing (this field is optional and commonly omitted at the pre-open stage), and with no raise amount or investor count yet disclosed, the offering cannot be sized relative to typical alternative-investment vehicles at this time.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govFilings on Record
Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.
In the Terminal
Filing events
1
latest Sep 24, 2026
Critical / warning
0 / 0
0 watch · 1 info
Statements extracted
0
none on file
NAV prints
0
none on file
Offering chains
1
pre_sale
Latest event New filer · Sep 24, 2026
SEC.govInvestor
- 1 filing event with values and deltas, latest 2026-09-24, and alerts on the next one
- 1 offering timeline: velocity, share raised, first-sale lag, stalled flags
Pro
- This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
- The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV
Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…
Related Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
N/A Vivace Longevity Fund I GP LLC
Executive Officer · Port Washington, NY
N/A Vivace Partners LLC
Executive Officer · Port Washington, NY
Dylan Livingston
Executive Officer · Port Washington, NY
Matthew Kaeberlein
Executive Officer · Port Washington, NY
Questions About Vivace Longevity Fund I LP
Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.
What is Vivace Longevity Fund I LP?
Vivace Longevity Fund I LP is a Delaware limited partnership organized in 2026 that filed a Form D with the SEC on September 24, 2026 as a venture capital fund. The filing claims Rule 506(b), Section 3(c), Section 3(c)(1) for an offering of pooled investment fund interests.
Is Vivace Longevity Fund I LP legit?
AltStreet does not rate legitimacy; it reports the public record. Vivace Longevity Fund I LP filed a Form D with the SEC on September 24, 2026 claiming Rule 506(b), Section 3(c), Section 3(c)(1). A Form D is a notice of an exempt offering, not a review or approval of it. No sales had been reported as of that notice. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.
Is Vivace Longevity Fund I LP registered with or approved by the SEC?
No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that Vivace Longevity Fund I LP claimed Rule 506(b), Section 3(c), Section 3(c)(1) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.
How much has Vivace Longevity Fund I LP raised?
Vivace Longevity Fund I LP reported that the first sale had not yet occurred as of the Form D filed September 24, 2026, so no amount sold or investor count is on file. The total offering amount is listed as indefinite.
Who can invest in Vivace Longevity Fund I LP?
The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. Because the fund also relies on Section 3(c)(1), it may have no more than 100 beneficial owners. The filing reports no non-accredited investors. The filing lists the minimum investment as $0, meaning no minimum was stated.
What is the minimum investment in Vivace Longevity Fund I LP?
The Form D lists the minimum investment as $0, which means the issuer did not state a minimum on the form. The offering documents, not the Form D, set the actual subscription terms.
Who is selling Vivace Longevity Fund I LP and how are they paid?
The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. Sales commissions are reported as $0 and finders' fees as $0. Form D allows these to be estimates.
Who is behind Vivace Longevity Fund I LP?
The Form D lists 4 related persons: Vivace Longevity Fund I GP LLC, executive officer (General Partner of the Issuer); Vivace Partners LLC, executive officer (Investment Manager of the Issuer); Dylan Venezia Livingston, executive officer (Managing Member of the General Partner and the Investment Manager); Matthew Robert Kaeberlein, executive officer (Managing Member of the General Partner and the Investment Manager). Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.
Where is Vivace Longevity Fund I LP located?
The issuer's address on its SEC filings is 171 Harbor Acres Rd, Port Washington, NY 11050. Its phone number of record is 425-213-3770. It is organized under the laws of Delaware.
How long is the Vivace Longevity Fund I LP offering open?
The issuer indicated that the offering is intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open, and no amendment is on record yet.
How large is Vivace Longevity Fund I LP?
The issuer declined to disclose its revenue range on the Form D, which the form permits.
Is this your company or fund?
Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.
Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.